Pilot study on the safety and feasibility of intravenous opioid agonist therapy (OAT) with Hydagelan® (hydromorphone hydrochloride) in Vienna.

and is associated with concomitant diseases and increased mortality., encompasses various psychological and physical dimensions, Opioid dependence: Opioid dependence is a serious and usually chronic disease that requires treatment

- Reduction of intravenous opioid use outside the medical setting. - Feasibility of implementation and execution

- Reduction in co-drug use - Safety of the intervention - Improvement in health status - Retention in treatment

No related papers found yet.

Austria